Guardant Health AMEA
Focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics.
Conquering Cancer With Data
Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer.
Join us and become a key player in solving complex healthcare challenges. Collaborate with top scientists, engineers, clinicians, and experts to make a real impact. We value your unique skills and are committed to providing rewarding careers for the curious and determined. Ready to make a difference?
Send Us Your CVA Global Effort
Cancer transcends borders, and so does our mission. We partner with laboratories and cancer centers worldwide to expand access to our liquid biopsy tests.
More than 60 countries offer Guardant Health testing, including across North and South America, Australia, Europe, the Middle East, China, Africa and more. Guardant Health has laboratories within the United States, United Kingdom, China, Japan, Spain, and Italy.
Explore Our Worldwide Footprint